Clinical Trial Update: The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients

View source ↗

Summary

This clinical trial registration describes a study of immunotherapy in first-line PD-L1-negative advanced non-small cell lung cancer and indicates the trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: NSCLC | Status: NOT_YET_RECRUITING